Tecentriq and Liver disease

• Generic Name: atezolizumab
• Dosage Forms: injection, solution
• Other Brand Names: Tecentriq

Tecentriq (atezolizumab) is a monoclonal antibody that affects the actions of the body's immune system. Atezolizumab strengthens your immune system to help your body fight against tumor cells.

Tecentriq is used to treat a certain type of bladder cancer and urinary tract cancer that has spread to other parts of the body or cannot be removed by surgery.

Your doctor may perform a biopsy to test your cancer for a protein called "PD-L1," or a specific genetic marker (an abnormal "EGFR" or "ALK" gene).

Tecentriq is used to treat non-small cell lung cancer that has spread to other parts of the body or cannot be removed by surgery.

Tecentriq is used in combination with the medicine paclitaxel protein-bound to treat a type of breast cancer called triple-negative breast cancer (TNBC) that has spread to other parts of the body or cannot be removed by surgery, and tests positive for “PD-L1", or a specific genetic marker (an abnormal "EGFR" or "ALK" gene).

Tecentriq is also used to treat a type of lung cancer called small cell lung cancer (SCLC).

Tecentriq is sometimes given after other cancer treatments have not worked or have stopped working.